OpenURL Connection Search

Select item for more details and to access through your institution.

Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge.
Published in:
Nature Medicine, 2014, v. 20, n. 10, p. 1126, doi. 10.1038/nm.3702
By:
- Stanley, Daphne A;
- Honko, Anna N;
- Asiedu, Clement;
- Trefry, John C;
- Lau-Kilby, Annie W;
- Johnson, Joshua C;
- Hensley, Lisa;
- Ammendola, Virginia;
- Abbate, Adele;
- Grazioli, Fabiana;
- Foulds, Kathryn E;
- Cheng, Cheng;
- Wang, Lingshu;
- Donaldson, Mitzi M;
- Colloca, Stefano;
- Folgori, Antonella;
- Roederer, Mario;
- Nabel, Gary J;
- Mascola, John;
- Nicosia, Alfredo
Publication type:
Article
CD8<sup>+</sup> cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates.
Published in:
Nature Medicine, 2011, v. 17, n. 9, p. 1128, doi. 10.1038/nm.2447
By:
- Sullivan, Nancy J;
- Hensley, Lisa;
- Asiedu, Clement;
- Geisbert, Thomas W;
- Stanley, Daphne;
- Johnson, Joshua;
- Honko, Anna;
- Olinger, Gene;
- Bailey, Michael;
- Geisbert, Joan B;
- Reimann, Keith A;
- Bao, Saran;
- Rao, Srinivas;
- Roederer, Mario;
- Jahrling, Peter B;
- Koup, Richard A;
- Nabel, Gary J
Publication type:
Article
Heterologous cAd3-Ebola and MVA-EbolaZ vaccines are safe and immunogenic in US and Uganda phase 1/1b trials.
Published in:
NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-00833-z
By:
- Happe, Myra;
- Hofstetter, Amelia R.;
- Wang, Jing;
- Yamshchikov, Galina V.;
- Holman, LaSonji A.;
- Novik, Laura;
- Strom, Larisa;
- Kiweewa, Francis;
- Wakabi, Salim;
- Millard, Monica;
- Kelley, Colleen F.;
- Kabbani, Sarah;
- Edupuganti, Srilatha;
- Beck, Allison;
- Kaltovich, Florence;
- Murray, Tamar;
- Tsukerman, Susanna;
- Carr, Derick;
- Ashman, Carl;
- Stanley, Daphne A.
Publication type:
Article
Ebola-GP DNA Prime rAd5-GP Boost: Influence of Prime Frequency and Prime/Boost Time Interval on the Immune Response in Non-human Primates.
Published in:
Frontiers in Immunology, 2021, v. 11, p. N.PAG, doi. 10.3389/fimmu.2021.627688
By:
- Marcus, Hadar;
- Thompson, Emily;
- Zhou, Yan;
- Bailey, Michael;
- Donaldson, Mitzi M.;
- Stanley, Daphne A.;
- Asiedu, Clement;
- Foulds, Kathryn E.;
- Roederer, Mario;
- Moliva, Juan I.;
- Sullivan, Nancy J.
Publication type:
Article
Demonstration of Cross-Protective Vaccine Immunity against an Emerging Pathogenic Ebolavirus Species.
Published in:
PLoS Pathogens, 2010, v. 6, n. 5, p. 1, doi. 10.1371/journal.ppat.1000904
By:
- Hensley, Lisa E.;
- Mulangu, Sabue;
- Asiedu, Clement;
- Johnson, Joshua;
- Honko, Anna N.;
- Stanley, Daphne;
- Fabozzi, Giulia;
- Nichol, Stuart T.;
- Ksiazek, Thomas G.;
- Rollin, Pierre E.;
- Wahl-Jensen, Victoria;
- Bailey, Michael;
- Jahrling, Peter B.;
- Roederer, Mario;
- Koup, Richard A.;
- Sullivan, Nancy J.
Publication type:
Article
A single-shot ChAd3-MARV vaccine confers rapid and durable protection against Marburg virus in nonhuman primates.
Published in:
Science Translational Medicine, 2022, v. 14, n. 675, p. 1, doi. 10.1126/scitranslmed.abq6364
By:
- Hunegnaw, Ruth;
- Honko, Anna N.;
- Wang, Lingshu;
- Carr, Derick;
- Murray, Tamar;
- Shi, Wei;
- Nguyen, Lam;
- Storm, Nadia;
- Dulan, Caitlyn N. M.;
- Foulds, Kathryn E.;
- Agans, Krystle N.;
- Cross, Robert W.;
- Geisbert, Joan B.;
- Cheng, Cheng;
- Ploquin, Aurélie;
- Stanley, Daphne A.;
- Geisbert, Thomas W.;
- Nabel, Gary J.;
- Sullivan, Nancy J.
Publication type:
Article
Vaccine Generation of Protective Ebola Antibodies and Identification of Conserved B-Cell Signatures.
Published in:
2018
By:
- Cagigi, Alberto;
- Misasi, John;
- Ploquin, Aurélie;
- Stanley, Daphne A;
- Ambrozak, David;
- Tsybovsky, Yaroslav;
- Mason, Rosemarie D;
- Roederer, Mario;
- Sullivan, Nancy J
Publication type:
journal article

Found: 7

Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge.

CD8<sup>+</sup> cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates.

Heterologous cAd3-Ebola and MVA-EbolaZ vaccines are safe and immunogenic in US and Uganda phase 1/1b trials.

Ebola-GP DNA Prime rAd5-GP Boost: Influence of Prime Frequency and Prime/Boost Time Interval on the Immune Response in Non-human Primates.

Demonstration of Cross-Protective Vaccine Immunity against an Emerging Pathogenic Ebolavirus Species.

A single-shot ChAd3-MARV vaccine confers rapid and durable protection against Marburg virus in nonhuman primates.

Vaccine Generation of Protective Ebola Antibodies and Identification of Conserved B-Cell Signatures.